title: A promoter polymorphism in CD36 is associated with an atherogenic lipid profile in a French general population.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Leprêtre
authors.forename: Claire
authors.initials: C
authors.lastname: Cheyssac
authors.forename: Philippe
authors.initials: P
authors.lastname: Amouyel
authors.forename: Philippe
authors.initials: P
authors.lastname: Froguel
authors.forename: Nicole
authors.initials: N
authors.lastname: Helbecque
mesh_terms: D000328:Adult; D000368:Aged; D018955:CD36 Antigens / Q000235:genetics*; D016022:Case-Control Studies; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D005602:France / Q000453:epidemiology; D005786:Gene Expression Regulation; D005838:Genotype; D006801:Humans; D006937:Hypercholesterolemia / Q000453:epidemiology / Q000235:genetics*; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000175:diagnosis / Q000453:epidemiology; D011110:Polymorphism, Genetic; D011336:Probability; D011401:Promoter Regions, Genetic; D012307:Risk Factors; D012494:Sampling Studies
chemical_list: D018955:CD36 Antigens; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL